Stock Price
6,361.50
Daily Change
-17.00 -0.27%
Monthly
5.77%
Yearly
5.80%
Q2 Forecast
6,221.55

Divis Laboratories Ltd reported INR181.51B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Aurobindo Pharma INR 525.46B 27.61B Sep/2025
Avita Medical AUD 56.39M 1.74M Dec/2025
Dianthus Therapeutics USD 530.92M 46.52M Dec/2025
Divis Laboratories Ltd INR 181.51B 12.19B Sep/2025
Ionis Pharmaceuticals USD 3.52B 490.91M Dec/2025
IQVIA Holdings USD 29.94B 1.22B Dec/2025
Lupin INR 335B 42.96B Sep/2025
Moderna USD 12.34B 203M Dec/2025
Organon & Co USD 13.55B 52M Sep/2025
Revvity USD 12.17B 29.46M Dec/2025
Tectonic Therapeutic USD 261.04M 15.96M Dec/2025
Tilray USD 2.1B 15.95M Sep/2025
Viatris USD 37.19B 727.3M Dec/2025
Xeris Pharmaceuticals USD 383.53M 13.34M Dec/2025